Synonyms
Status
Molecule Category Free-form
ATC C08CA04
UNII CZ5312222S
EPA CompTox DTXSID6023363

Structure

InChI Key ZBBHBTPTTSWHBA-UHFFFAOYSA-N
Smiles COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
InChI
InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H29N3O6
Molecular Weight 479.53
AlogP 3.68
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 9.0
Polar Surface Area 111.01
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 35.0
Assay Description Organism Bioactivity Reference
Inhibition of adenylyl cyclase by A3 agonist IB-MECA(10e-6M) in CHO cell membranes expressing rat Adenosine A3 receptor Rattus norvegicus 27.2 %
Inhibition of adenylyl cyclase by A3 agonist IB-MECA(10e-7M) in CHO cell membranes expressing rat Adenosine A3 receptor Rattus norvegicus 7.94 %
Percentage inhibition against beta-Lactamase in the absence of detergent Triton X-100 was determined at a concentration of 100 uM Escherichia coli 81.0 %
Percentage inhibition against beta-Lactamase in the presence of detergent 0.01% Triton X-100 was determined at a concentration of 100 uM Escherichia coli 33.0 %
Percentage inhibition of Beta-lactamase at KPi (Potassium Phosphate) stock concentration of 13.5 uM Escherichia coli 32.0 %
Fold decrease in IC50 vs beta-lactamase on pre-incubation Escherichia coli 50.0
Inhibition of [3H]nitrendipine binding to L-type calcium channel from rat brain cortex homogenate Rattus norvegicus 0.84 nM
Fold increase in IC50 vs chymotrypsinogen with 0.2 mg/ml saponin None 2.0
Fold decrease in IC50 vs chymotrypsinogen on pre-incubation None 3.0
Inhibition of human cytochrome P450 2C9 Homo sapiens 280.0 nM
Inhibition of human cytochrome P450 3A4 None 420.0 nM
Fold increase in IC50 vs malate dehydrogenase (MDH) with 1 mg/ml saponin None 49.0
Inhibition of P-glycoprotein using calcein-AM assay transfected in porcine PBCEC None 950.0 nM
Inhibition of P-gp was determined using rhodamine-assay in human CaCo-2 cells None 100.0 %
Calcium antagonistic activity was evaluated from the inhibition of CaCl2-induced contraction of depolarized pig coronary artery Sus scrofa 0.3 nM
Inhibition of [3H]nitrendipine binding to L-type calcium channels of rat cerebral cortex Rattus norvegicus 2.66 nM
Calcium antagonistic activity was evaluated by in vitro inhibition of [3H]nitrendipine binding on rat cerebral cortex Rattus norvegicus 0.026 nM
Fold increase in IC50 vs beta-lactamaase with 0.1 mg/mL saponin Escherichia coli 50.0
Fold increase in IC50 vs beta-lactamase with 10x increased enzyme Escherichia coli 50.0
Agonist activity at mouse TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium influx Mus musculus 500.0 nM
Inhibition of polyhistidine tagged yeast prion protein Sup35 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid polymerization at 50 uM by thioflavin T fluorescence assay relative to untreated control Saccharomyces cerevisiae 61.5 %
Inhibition of polyhistidine tagged yeast prion protein Sup35 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid polymerization at 50 uM in presence of 5 mg/ml BSA by thioflavin T fluorescence assay relative to untreated control Saccharomyces cerevisiae 0.0 %
Inhibition of mouse prion protein (89-230) assessed as inhibition of amyloid polymerization at 50 uM by thioflavin T fluorescence assay relative to untreated control Mus musculus 22.7 %
Inhibition of yeast prion protein Sup35 infection of PSI yeast spheroplast cells at 100 uM Saccharomyces cerevisiae 50.0 %
Inhibition of polyhistidine tagged yeast prion protein Sup35 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid polymerization at 100 uM by thioflavin T fluorescence assay relative to untreated control Saccharomyces cerevisiae 55.0 %
Inhibition of polyhistidine tagged yeast prion protein Sup35 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid polymerization preincubation of seed fibers and compound for 5 mins at 100 uM by thioflavin T fluorescence assay relative to untreated control Saccharomyces cerevisiae 88.0 %
TP_TRANSPORTER: increase in Rhodamine 123 intracellular accumulation (R123: 150 uM, Nicardipine: 2 ug/mL) in MDR1-expressing NIH3T3 cells None 100.0 %
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting Homo sapiens 65.1 %
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 10.1 %
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 31.8 %
Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation at 20 uM after 45 mins by spectrophotometric analysis relative to control Mus musculus 55.0 %
Inhibition of potassium chloride-induced contraction in Rattus norvegicus albino (rat) thoracic artery at 10'-5 mol/l after 10 min Rattus norvegicus 15.9 %
Inhibition of barium chloride-induced contraction inRattus norvegicus albino (rat) ileum at 10'-5 mol/l after 10 min Rattus norvegicus 70.0 %
Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit Homo sapiens 250.0 nM
Inhibition of CYP3A4 in human liver microsomes using testosterone substrate by LC-MS/MS method Homo sapiens 380.0 nM
Inhibition of CYP2C9 in human liver microsomes using tolbutamide substrate by LC-MS/MS method Homo sapiens 660.0 nM
Inhibition of CYP2C19 in human liver microsomes using omeprazole substrate by LC-MS/MS method Homo sapiens 560.0 nM
Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate after 8 mins by LC-MS/MS analysis Homo sapiens 378.0 nM
Induction of mitochondrial dysfunction in Sprague-Dawley rat liver mitochondria assessed as inhibition of mitochondrial respiration per mg mitochondrial protein measured for 20 mins by A65N-1 oxygen probe based fluorescence assay Rattus norvegicus 100.0 nM
Inhibition of NorA in Staphylococcus aureus SA1199B harboring GrlA A116E mutant assessed as inhibition of ethidium bromide efflux at 50 uM measured after 5 mins by fluorometric method relative to control Staphylococcus aureus 77.1 %

Related Entries

Cross References

Resources Reference
ChEBI 7550
ChEMBL CHEMBL1484
DrugBank DB00622
DrugCentral 1909
FDA SRS CZ5312222S
Human Metabolome Database HMDB0014760
Guide to Pharmacology 2559
KEGG C07264
PharmGKB PA450620
PubChem 4474
SureChEMBL SCHEMBL34277